234 related articles for article (PubMed ID: 33346201)
1. Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.
O'Brien VP; Joens MS; Lewis AL; Gilbert NM
J Vis Exp; 2020 Dec; (166):. PubMed ID: 33346201
[TBL] [Abstract][Full Text] [Related]
2. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease.
Gilbert NM; O'Brien VP; Lewis AL
PLoS Pathog; 2017 Mar; 13(3):e1006238. PubMed ID: 28358889
[TBL] [Abstract][Full Text] [Related]
3. Bladder Exposure to
O'Brien VP; Lewis AL; Gilbert NM
Front Cell Infect Microbiol; 2021; 11():788229. PubMed ID: 34938672
[TBL] [Abstract][Full Text] [Related]
4. Detection of intracellular bacterial communities in human urinary tract infection.
Rosen DA; Hooton TM; Stamm WE; Humphrey PA; Hultgren SJ
PLoS Med; 2007 Dec; 4(12):e329. PubMed ID: 18092884
[TBL] [Abstract][Full Text] [Related]
5. Uropathogenic
Li ZP; Li J; Li TL; Song ZY; Gong XZ
Front Cell Infect Microbiol; 2024; 14():1322119. PubMed ID: 38638825
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
[TBL] [Abstract][Full Text] [Related]
7. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
8. A non-canonical autophagy-dependent role of the ATG16L1
Wang C; Bauckman KA; Ross ASB; Symington JW; Ligon MM; Scholtes G; Kumar A; Chang HW; Twentyman J; Fashemi BE; Xavier RJ; Mysorekar IU
Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568
[TBL] [Abstract][Full Text] [Related]
9. Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment.
Eberly AR; Floyd KA; Beebout CJ; Colling SJ; Fitzgerald MJ; Stratton CW; Schmitz JE; Hadjifrangiskou M
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28973965
[TBL] [Abstract][Full Text] [Related]
10. Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.
Stærk K; Grønnemose RB; Palarasah Y; Lund L; Andersen TE
Microb Pathog; 2022 Dec; 173(Pt A):105817. PubMed ID: 36244593
[TBL] [Abstract][Full Text] [Related]
11. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic
Sawant NV; Chang SS; Pandit KA; Khekare P; Warner WR; Zimmern PE; De Nisco NJ
Microbiol Spectr; 2024 Mar; 12(3):e0271223. PubMed ID: 38240572
[TBL] [Abstract][Full Text] [Related]
12. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
[TBL] [Abstract][Full Text] [Related]
13. Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo.
Wang C; Mendonsa GR; Symington JW; Zhang Q; Cadwell K; Virgin HW; Mysorekar IU
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):11008-13. PubMed ID: 22715292
[TBL] [Abstract][Full Text] [Related]
14. Vaginal Inoculation of Uropathogenic Escherichia coli during Estrus Leads to Genital and Renal Colonization.
Robinson CK; Saenkham-Huntsinger P; Hanson BS; Adams LG; Subashchandrabose S
Infect Immun; 2022 Apr; 90(4):e0053221. PubMed ID: 35357220
[TBL] [Abstract][Full Text] [Related]
15. Bladder infection with uropathogenic
Montalbetti N; Dalghi MG; Bastacky SI; Clayton DR; Ruiz WG; Apodaca G; Carattino MD
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F1-F13. PubMed ID: 34779263
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.
Wang C; Symington JW; Ma E; Cao B; Mysorekar IU
Infect Immun; 2013 Mar; 81(3):733-9. PubMed ID: 23264047
[TBL] [Abstract][Full Text] [Related]
17. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
Mulvey MA; Schilling JD; Martinez JJ; Hultgren SJ
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8829-35. PubMed ID: 10922042
[TBL] [Abstract][Full Text] [Related]
18. Distinct Morphological Fates of Uropathogenic
Iosifidis G; Duggin IG
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32540870
[TBL] [Abstract][Full Text] [Related]
19.
Gilbert NM; O'Brien VP; Waller C; Batourina E; Mendelsohn CL; Lewis AL
Front Cell Infect Microbiol; 2022; 12():909799. PubMed ID: 35782131
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract.
Kurimura Y; Nishitani C; Ariki S; Saito A; Hasegawa Y; Takahashi M; Hashimoto J; Takahashi S; Tsukamoto T; Kuroki Y
J Biol Chem; 2012 Nov; 287(47):39578-88. PubMed ID: 23012359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
